Anti-infective potentials of dabigatran and direct oral anticoagulants in patients with cardiac implantable electronic devices

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Assistant Professor Yap-Hang Will Chan

The University of Hong Kong, Hong Kong (Hong Kong)

8 More presentations in this session

Presentation thumbnail

Discussant - Pharmacotherapy

Presentation thumbnail

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Ph2 Trial of Pacibekitug SC Quarterly or Monthly in Patients with Elevated hs-CRP and Chronic Kidney Disease: TRANQUILITY 90-Day Results

Professor D. Bhatt (New York City, US)

Presentation thumbnail

SGLT2 inhibitors on the prevention of contrast-induced acute kidney injury in patients with type 2 diabetes after coronary revascularization: a systematic review and meta-analysis

Doctor K. Dimitriadis (Athens, GR)

Presentation thumbnail

Comparative effectiveness of angiotensin ii receptor blockers versus angiotensin-converting enzyme inhibitors in acute myocardial infarction

Doctor P. Sun (Tianjin, CN)

Presentation thumbnail

GLP-1 RAs reduce mortality and cardiovascular events across the spectrum of treated patients: a systematic review and meta-analysis

Doctor M. Galli (Rome, IT)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Pharmacotherapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations

Congress Session

Managing infective endocarditis: guidelines and beyond

Congress Session

Registries on atrial fibrillation and sudden death

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources